共 161 条
- [1] Kicman AT(2008)Pharmacology of anabolic steroids Brit J Pharmacol 154 502-521
- [2] Bhasin S(1996)The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men N Engl J Med 335 1-7
- [3] Storer TW(2012)Anabolic androgenic steroids in the general population: user characteristics and associations with substance use Eur Addict Res 18 83-90
- [4] Berman N(2014)The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates Am J Addiction 23 371-377
- [5] Callegari C(2013)A national study of substance use behaviors among NCAA male athletes who use banner performance enhancing substances Drug Alcohol Depend 131 50-55
- [6] Clevenger B(2018)The prevalence of anabolic androgenic steroid misuse and its associated factors among bodybuilders in Shiraz, Iran Int J Nutr Sci 3 151-156
- [7] Phillips J(2008)Prevalence of doping agents’ abuse and male bodybuilders’ knowledge about their side effects in Kermanshah gymnasiums (2004) J Kermanshah Univ Med Sci (behbood) 11 418-427
- [8] Bunnell TJ(2020)Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids Scand J Med Sci Sports 30 531-539
- [9] Tricker R(2019)Designer anabolic steroids: a challenge for toxicologists Toxicol Anal Clin 31 293-297
- [10] Shirazi A(2010)Adverse health effects of anabolic–androgenic steroids Regul Toxicol Pharmacol 57 117-123